Orange County Business Journal

Tease photo

Allergan Releases Critical E-Mails in Takeover Fight

Irvine-based Allergan Inc. today released negative comments made about suitor Valeant Pharmaceuticals International Inc. by bankers with Morgan Stanley—one of the investment banks working for Valeant in its hostile $53 billion takeover attempt of Allergan.

I-Flow Gets New Headquarters to Go With Fresh Products

HEALTHCARE: Parent firm set for public company spinoff

Medical device maker I-Flow LLC is settling into its new Irvine headquarters and preparing for life as a unit of a yet-to-be-created public company.

Allergan’s Summer Schedule: Test of Endurance

HEALTHCARE: Time could be key to holding off takeover bid

It looks as though there’s no summer break in store for Allergan Inc. Chairman and Chief Executive David Pyott, who appears ready to spend the coming months fighting a hostile takeover attempt by Valeant Pharmaceuticals International Inc.

Innovation Institute Establishes Venture

The La Palma-based Innovation Institute, a provider of business services, products and investment management services to health systems, formed a new staffing business.

Manufacturer Opens Irvine R&D Center

BIT Group, a contract developer and manufacturer of diagnostic testing products, opened a research and development center in the Irvine Spectrum.

Stock Guru: Beckman Coulter Parent Could Break Up

Cramer Speculates Danaher Would Be Stronger If Split

Danaher Corp., the conglomerate that owns Brea-based medical testing company Beckman Coulter Inc., could be in line for a potential breakup, according to quirky stock guru Jim Cramer.

Tease photo

Ackman, Pershing Square Sue Allergan

Irvine-based drug maker Allergan Inc. was sued today by activist investor Bill Ackman’s Pershing Square Capital Management LP.

Tease photo

Allergan Board Rejects New Valeant Bid

Irvine-based Allergan Inc. said today that its board rejected a revised hostile takeover bid worth about $53 billion from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP.

Tease photo

Innovation Institute Forms Staffing Company

The La Palma-based Innovation Institute, a provider of business services, products and investment management services to health systems, said today that it formed a new staffing business.

Ensign Shares Plummet After REIT Spinoff, Rise on Debut

HEALTHCARE: New entity owns nursing home properties

Orange County has a new publicly traded healthcare company among its ranks.

Growing Sector Could Accelerate Quality Systems

Revenue Cycle Managing Has Much Room to Grow

Irvine-based Quality Systems Inc. will get a bump from the growing revenue cycle management sector in coming years, according to a recently issued analyst report.

Tease photo

Innovation Institute Forms Staffing Company

The La Palma-based Innovation Institute, a provider of business services, products and investment management services to health systems, said today that it formed a new staffing business.

Tease photo

Miller Children’s Hospital Changes Name

Fountain Valley-based MemorialCare Health System said that its Miller Children’s Hospital Long Beach is now known as Miller Children’s & Women’s Hospital Long Beach.

Tease photo

Ackman Says He'll Seek to Replace Allergan Directors

Activist investor Bill Ackman said today that he and his Pershing Square Capital Management LP will call for a special shareholders’ meeting of Allergan Inc. in order to remove six of its directors—the latest in the ongoing hostile takeover effort by Valeant Pharmaceuticals International Inc.

Tease photo

Valeant, Ackman Hike Allergan Bid Again

Valeant Pharmaceuticals International Inc. today added more cash to its hostile takeover bid for Irvine-based Allergan Inc.

FDA OK for Next Phase of Direct Flow Valve Trial

Results From Europe Show ‘Positive Trend’

A federal approval and newly released clinical trial results have put a spotlight on Direct Flow Medical Inc., a Santa Rosa-based heart valve startup that makes its devices in Lake Forest.

Numbers Give New View on Allergan Takeover Attempt

HEALTHCARE: Valeant’s sweetened bids look short in expectations game

There was no shortage of numbers punctuating the battle for Allergan Inc. last week, when the sum total pointed to a possible shift in favor of the Irvine-based drug maker’s effort to stave off a hostile takeover bid by Valeant Pharmaceuticals International Inc.

Tease photo

Valeant, Ackman Hike Allergan Bid Again

Valeant Pharmaceuticals International Inc. today added more cash to its hostile takeover bid for Irvine-based Allergan Inc.

Tease photo

Ensign Set to Complete CareTrust Spinout

Mission Viejo-based nursing home operator Ensign Group Inc. will complete the spin-off of its real estate holdings into a separate publicly traded company after the close of trading Monday.

Bay Area Device Maker Taps OC Vet

HEALTHCARE: New CEO will establish office in Aliso Viejo

Focal Therapeutics Inc., a medical device company in the Bay Area, has hired an Orange County-based chief executive and plans to establish a presence in Aliso Viejo.

Device Maker to Get $1B+ in Settlement

Irvine-based Edwards Lifesciences Corp. will receive more than $1 billion from rival Medtronic Inc. to settle a patent lawsuit.

Pyott’s Plan: Keep Calm and Counterpunch

Allergan Boss Works Back Channels to Fend Off Valeant

A team of specialists will continue Allergan Inc.’s battle for the minds and wallets of shareholders this week, when Valeant Pharmaceuticals International Inc. is expected to hike its $47 billion hostile bid for the Irvine-based drug maker.

St. Joseph Health Chief Executive Lauded

Deborah Proctor, chief executive of Irvine-based St. Joseph Health, received the 2014 Woman of the Year award from the Women in Health Administration of Southern California.

Tease photo

Investors: Valeant Must Hike Allergan Bid

Valeant Pharmaceuticals International Inc. should raise its unsolicited offer to buy Irvine-based Allergan Inc. to roughly $53.5 billion to $59.5 billion or $180 to $200 a share, according to an investor survey released today by JP Morgan.

Tease photo

Proctor Wins Health Administration Group Award

Deborah Proctor, chief executive of Irvine-based St. Joseph Health, received the 2014 “woman of the year” award from the Southern California Women in Health Administration.

Tease photo

Proctor Wins Health Administration Group Award

Deborah Proctor, chief executive of Irvine-based St. Joseph Health, received the 2014 “woman of the year” award from the Southern California Women in Health Administration.

Tease photo

Edwards in Line for $1B Settlement From Medtronic

Irvine-based Edwards Lifesciences Corp. will receive more than $1 billion from rival Medtronic Inc. to settle a patent lawsuit.

Tease photo

Allergan Board Stands By Pyott, Refutes Ackman

Irvine-based Allergan Inc. on Monday fired back at activist investor Bill Ackman in a tersely worded letter prompted by Ackman’s conflict of interest charges against Chairman and Chief Executive David Pyott.

Tease photo

Allergan Board Stands By Pyott, Refutes Ackman

Irvine-based Allergan Inc. today fired back at activist investor Bill Ackman in a tersely worded letter prompted by Ackman’s conflict of interest charges against Chairman and Chief Executive David Pyott.

Mallinckrodt Boss Calls Questcor ‘Ideal Strategic Fit’

Says It Can Maximize Value of Questcor Drugs

Anaheim-based Questcor Pharmaceuticals Inc. will help create a “strong, nicely balanced specialty pharmaceutical platform” for Mallinckrodt PLC, according to the latter’s chief executive.

Name Game: Covenant Now St. Joseph Hoag Health

HEALTHCARE: Aims to play up strength of individual brands

Irvine-based St. Joseph Health and Hoag Memorial Hospital Presbyterian are mixing the old with the new when it comes to their year-old affiliation to create an integrated regional health network.

Tease photo

Analyst: Allergan Likely to Stand Alone

Allergan Inc. is likely to remain a standalone company, according to recent report by a veteran analyst.

Tease photo

Analyst: Allergan Likely to Stand Alone

Allergan Inc. is likely to remain a standalone company, according to recent report by a veteran analyst.

Tease photo

Valeant to Hike Allergan Bid

Valeant Pharmaceuticals International Inc. said today that it will put in an “improved offer” to buy Irvine-based Allergan Inc.

Tease photo

Masimo Shares Rise

Shares of Irvine-based Masimo Corp. rose Monday on news that it is cooperating with a federal investigation and has received a grand jury subpoena on documents relating to a pair of its monitors.

Tease photo

Masimo Shares Rise

Shares of Irvine-based Masimo Corp. rose today on news that it is cooperating with a federal investigation and has received a grand jury subpoena on documents relating to a pair of its monitors.

Tease photo

Allergan Board Rejects Valeant Bid

Irvine-based drug maker Allergan Inc. today rejected a hostile $46 billion takeover bid by Valeant Pharmaceuticals International Inc.

Allergan’s Influence

Drug Maker at Center of Hostile Bid Hub of Executive Talent

Allergan Inc., the Irvine-based drug maker that’s currently the target of a hostile takeover attempt, has been a farm team of sorts when it comes to Orange County’s vibrant drug and medical device sectors.

Sabra, Ensign Making More Deals for Properties

Out-of-State Buys Part of Continued Expansions

Sabra Healthcare REIT Inc. and Ensign Group Inc. are buying more properties.

Tease photo

Financial Times: Allergan to Reject Valeant Bid

Irvine-based drug maker Allergan Inc. could reject a hostile $47 billion takeover bid by Valeant Pharmaceuticals International Inc. as early as Monday, according to a report today by the Financial Times.

Tease photo

Valeant, Ackman Want to Change Allergan Board

Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP said Thursday they would team up in an attempt to force changes to the board of Irvine-based drug maker Allergan Inc.

Tease photo

Valeant, Ackman Want to Change Allergan Board

Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP said today they would team up in an attempt to force changes to the board of Irvine-based drug maker Allergan Inc.

Tease photo

Allergan Beats on Q1, Lifts Guidance amid Valeant Bid

Irvine-based Allergan Inc. on Wednesday reported first-quarter profit and revenue that surpassed analysts’ expectations and hiked its full-year guidance.

Tease photo

MemorialCare Teaming With Cedars-Sinai on Investment Fund

Fountain Valley-based MemorialCare Health System said today that it will partner with Cedars-Sinai Health System in Los Angeles to establish Summation Health Ventures.

Tease photo

Sabra to Sell 7 Million Shares of Stock

Sabra Health Care REIT Inc. said Wednesday that it was offering 7 million shares of its common stock priced at $28.35 a share.

Tease photo

Sabra to Sell 7 Million Shares of Stock

Sabra Health Care REIT Inc. said today that it was offering 7 million shares of its common stock priced at $28.35 a share.

Tease photo

MemorialCare Teaming With Cedars-Sinai on Investment Fund

Fountain Valley-based MemorialCare Health System said today that it will partner with Cedars-Sinai Health System in Los Angeles to establish Summation Health Ventures.

Tease photo

Allergan Beats on Q1, Lifts Guidance amid Valeant Bid

Irvine-based Allergan Inc. today reported first-quarter profit and revenue that surpassed analysts’ expectations and hiked its full-year guidance.

Tease photo

Allergan Investor Touts Valeant’s ‘Superior’ Bid in Letter

Irvine-based Allergan Inc. should “make the best possible deal” with Canada’s Valeant Pharmaceuticals International Inc. or identify a “superior transaction with another company,” activist investor Bill Ackman said Monday.

Allergan Investor Touts Valeant’s ‘Superior’ Bid in Letter

Irvine-based Allergan Inc. should “make the best possible deal” with Canada’s Valeant Pharmaceuticals International Inc. or identify a “superior transaction with another company,” activist investor Bill Ackman said today.